Hepatitis C: Grading and Staging by MR

This study has been completed.
Sponsor:
Information provided by:
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
ClinicalTrials.gov Identifier:
NCT00059397
First received: April 24, 2003
Last updated: March 17, 2010
Last verified: March 2010
  Purpose

To compare MR imaging findings with biopsy for grading and staging early hepatitis C.


Condition
Hepatitis

Study Type: Observational
Study Design: Time Perspective: Prospective
Official Title: Hepatitis C: Grading and Staging by MR

Resource links provided by NLM:


Further study details as provided by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK):

Estimated Enrollment: 80
Study Start Date: April 2003
  Eligibility

Ages Eligible for Study:   18 Years to 75 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Referral only

  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00059397

Locations
United States, Pennsylvania
Thomas Jefferson University Hospital
Philadelphia, Pennsylvania, United States, 19107
Sponsors and Collaborators
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00059397     History of Changes
Other Study ID Numbers: R03 (DK62765) (completed 2007)
Study First Received: April 24, 2003
Last Updated: March 17, 2010
Health Authority: United States: Federal Government

Keywords provided by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK):
Hepatitis C

Additional relevant MeSH terms:
Hepatitis
Hepatitis A
Hepatitis C
Liver Diseases
Digestive System Diseases
Hepatitis, Viral, Human
Virus Diseases
Enterovirus Infections
Picornaviridae Infections
RNA Virus Infections
Flaviviridae Infections

ClinicalTrials.gov processed this record on June 17, 2013